Management of Pre-eclampsia

Diagnosis and Initial Assessment

• The American College of Cardiology recommends that pre-eclampsia be diagnosed by new-onset hypertension (≥140/90 mmHg) after 20 weeks of gestation with proteinuria or evidence of end-organ damage 1, 2
• All women with pre-eclampsia should be hospitalized initially to confirm diagnosis, assess severity, and monitor progression 2
• Maternal monitoring should include blood pressure measurements every 4 hours (more frequently if severe) 1, 3
• The American Heart Association recommends that maternal monitoring should also include clinical assessment including evaluation for clonus and neurological symptoms 1
• At least twice weekly blood tests for hemoglobin, platelet count, liver enzymes, and renal function including uric acid should be performed 1, 4

Blood Pressure Management

• The American College of Obstetricians and Gynecologists recommends that severe hypertension (>160/110 mmHg) requires urgent treatment in a monitored setting using oral nifedipine (10 mg, repeat every 20 minutes to maximum 30 mg) 2, 5
• IV labetalol (20 mg bolus, then 40 mg if needed after 10 minutes, followed by 80 mg every 10 minutes to maximum 220 mg) can also be used to treat severe hypertension 2, 5
• For non-severe hypertension (≥140/90 mmHg), the American Heart Association recommends treating with oral antihypertensives aiming for target diastolic BP of 85 mmHg and systolic BP between 110-140 mmHg 2

Seizure Prevention with Magnesium Sulfate

• The American College of Obstetricians and Gynecologists recommends that magnesium sulfate should be administered for convulsion prophylaxis in women with pre-eclampsia and severe hypertension 2, 3
• Magnesium sulfate dosing for pre-eclampsia/eclampsia should be continued for 24 hours postpartum 3, 4

Fluid Management

• The American Society of Nephrology recommends limiting total fluid intake to 60-80 mL/hour to avoid pulmonary edema 3, 4
• Aim for euvolemia; avoid "running dry" as this increases risk of acute kidney injury 3

Fetal Monitoring

• The American Institute of Ultrasound in Medicine recommends that initial assessment should confirm fetal well-being 1, 2
• Serial ultrasound surveillance including fetal biometry, amniotic fluid assessment, and umbilical artery Doppler should be performed 1, 4

Timing of Delivery

• The American College of Obstetricians and Gynecologists recommends that delivery is the definitive treatment for pre-eclampsia 1, 2
• Deliver at 37 weeks' gestation or earlier if any of the following develop: repeated episodes of severe hypertension despite treatment with 3 classes of antihypertensives 1

Postpartum Management

• The American Heart Association recommends continuing close monitoring for at least 3 days postpartum as eclampsia can still develop 1, 3
• Monitor BP at least every 4 hours while awake 1, 3
• Continue antihypertensives and taper slowly after days 3-6 postpartum 1, 3

Prevention Strategies for High-Risk Women

• The American College of Obstetricians and Gynecologists recommends that low-dose aspirin (75-162 mg/day) before 16 weeks' gestation (definitely before 20 weeks) for women with strong clinical risk factors 1, 6
• Supplemental calcium (1.2-2.5 g/day) if intake is likely low (<600 mg/day) should be considered 1

Special Considerations

• The American Heart Association recommends that women with pre-eclampsia should be counseled about increased lifetime cardiovascular risk 1, 7
• Regular exercise during pregnancy may help reduce the likelihood of hypertension 1

Management of Preeclampsia and Eclampsia

Blood Pressure Management

• The European Heart Journal recommends avoiding sublingual or rapid IV administration of calcium channel blockers to prevent excessive blood pressure reduction leading to myocardial infarction or fetal distress, and also advises against combining calcium blockers with IV magnesium due to risk of myocardial depression 8
• The European Heart Journal suggests that ACE inhibitors are absolutely contraindicated during second and third trimesters due to renal dysgenesis 8
• The European Heart Journal advises against using sublingual nifedipine due to risk of precipitous blood pressure drops 8
• The European Heart Journal recommends not combining IV magnesium with calcium channel blockers due to myocardial depression risk 8

Fluid Management

• The European Heart Journal recommends strictly limiting total fluid intake to 60-80 mL/hour to prevent pulmonary edema, and aiming for euvolemia, while avoiding "running dry" as this increases acute kidney injury risk, and also states that diuretics are contraindicated in preeclampsia as they further reduce plasma volume 8

Timing of Delivery by Gestational Age

• The European Heart Journal recommends administering corticosteroids for 48 hours to accelerate fetal lung maturation if gestation <34 weeks 8

Mandatory Immediate Delivery Indications

• The European Heart Journal recommends delivering immediately if there are repeated episodes of severe hypertension despite treatment with 3 classes of antihypertensives 8
• The European Heart Journal suggests delivering immediately in case of placental abruption 8
• The European Heart Journal recommends delivering immediately in case of non-reassuring fetal status 8

Management of Pregnant Women with Prior History of Preeclampsia

Risk Assessment and Counseling

• Women with a prior episode of preeclampsia have an approximately 15 % risk of recurrence and a 15 % risk of gestational hypertension in subsequent pregnancies; the magnitude of risk rises with earlier onset, greater severity, and the presence of chronic conditions such as hypertension, diabetes, renal disease, or autoimmune disorders. 9
• These women also face increased lifetime cardiovascular risk, including higher incidence of stroke, cardiovascular disease, type 2 diabetes, venous thromboembolism, and chronic kidney disease compared with those who had normotensive pregnancies. 9

Primary Prevention

• Low‑dose aspirin (75–162 mg daily) should be started before 16 weeks’ gestation (ideally by 12 weeks) in all women with a history of preeclampsia; this regimen has the strongest evidence for preventing recurrent preterm preeclampsia. 10
• Calcium supplementation of 1.2–2.5 g elemental calcium per day is recommended when dietary calcium intake is likely < 600–800 mg/day, particularly in populations with low baseline intake. 9

Antenatal Surveillance

• Home blood‑pressure monitoring between clinic visits is advised to detect early rises in pressure. 9
• Fluid intake should be limited to 60–80 mL per hour to reduce the risk of pulmonary edema, while aiming for euvolemia rather than aggressive restriction. [9][11]

Acute Management of Recurrent Preeclampsia

• Magnesium sulfate is administered for seizure prophylaxis: a 4–5 g IV loading dose followed by a continuous infusion of 1–2 g per hour, continued for 24 hours postpartum. Clinical monitoring (deep‑tendon reflexes, respiratory rate, urine output ≥ 30 mL/h) is used to detect toxicity. 11

Postpartum Care

• Blood‑pressure monitoring should be performed every 4–6 hours while awake for at least 3 days after delivery, because postpartum preeclampsia and eclampsia can develop. [9][11]
• Antihypertensive therapy should be continued or restarted after delivery and tapered slowly only after days 3–6 postpartum unless blood pressure falls below 110/70 mmHg. [9][11]
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) should be avoided in women with preeclampsia, especially if acute kidney injury is present; alternative analgesics are recommended. [9][11]
• A clinical review within 1 week is advised for any woman still requiring antihypertensives at discharge. 9
• All patients should be re‑evaluated at 3 months postpartum to confirm normalization of blood pressure, urinalysis, and laboratory studies; persistent abnormalities warrant further investigation. [9][11]
• Screening for postpartum depression, anxiety, and post‑traumatic stress disorder should be incorporated into the 3‑month follow‑up. 9

Long‑Term Follow‑Up

• Lifelong cardiovascular risk monitoring is recommended, including periodic blood‑pressure checks, fasting lipid panels, and blood‑glucose screening, together with lifestyle counseling on weight management and regular aerobic exercise. [9][11]

Management of Pulmonary Edema in Pre‑eclampsia – Evidence‑Based Recommendations

Immediate Stabilization

• Restrict intravenous fluid intake to 60–80 mL per hour to prevent worsening pulmonary edema – based on European Society of Cardiology guidance (European Heart Journal, 2020) 12.
• Provide supplemental oxygen promptly and titrate to keep peripheral oxygen saturation > 95 % – European Society of Cardiology recommendation (European Heart Journal, 2020) 13.

Cardiovascular Management

• Start an intravenous nitroglycerin infusion at 5 µg/min for afterload reduction, increasing by 5 µg/min every 5 minutes as needed – European Society of Cardiology protocol (European Heart Journal, 2020) 14.
• Treat severe hypertension (≥ 160/110 mmHg) within 15 minutes using either intravenous labetalol (initial 20 mg bolus, then titrated up to a maximum of 220 mg) or intravenous nicardipine (starting 5 mg/h, titrated up to 15 mg/h) – European Society of Cardiology algorithm (European Heart Journal, 2020) [15][14]12.
• Aim for a target blood pressure of 110–140 mmHg systolic and 85–100 mmHg diastolic after initial control – European Society of Cardiology target range (European Heart Journal, 2020) 12.

Diagnostic Evaluation

• Perform focused physical examination for pulmonary crackles, increased work of breathing, and monitor oxygen saturation – European Society of Cardiology clinical assessment (European Heart Journal, 2020) [12][13].
• Screen for signs of impending eclampsia (hyper‑reflexia, papilledema, altered mental status) and hepatic tenderness suggestive of HELLP syndrome – European Society of Cardiology recommendations (European Heart Journal, 2020) [12][13].
• Measure NT‑proBNP when cardiac dysfunction is suspected, recognizing that levels are often elevated in pre‑eclampsia even without true cardiac pathology – European Society of Cardiology laboratory guidance (European Heart Journal, 2020) [12][13].
• Obtain LDH and haptoglobin levels to evaluate for hemolysis – European Society of Cardiology laboratory panel (European Heart Journal, 2020) 13.
• Use bedside echocardiography to assess cardiac function and exclude peripartum cardiomyopathy; approximately 30 % of pre‑eclamptic patients with underlying heart disease develop heart failure – European Society of Cardiology imaging recommendation (European Heart Journal, 2020) [12][13].

Delivery Planning

• Proceed with delivery as the definitive therapy after maternal stabilization, irrespective of gestational age – European Society of Cardiology obstetric guideline (European Heart Journal, 2020) [15][14].
• Prefer vaginal delivery unless obstetric indications mandate cesarean section – European Society of Cardiology obstetric recommendation (European Heart Journal, 2020) 15.
• If gestational age is < 34 weeks, administer antenatal corticosteroids for fetal lung maturation only when delivery can be safely delayed for at least 48 hours – European Society of Cardiology perinatal guidance (European Heart Journal, 2020; additional reference 2003) [15][16].
• Continue antihypertensive therapy throughout labor and delivery to keep blood pressure below 160/110 mmHg – European Society of Cardiology intrapartum protocol (European Heart Journal, 2020) [15][14].

Medication Considerations

• Avoid sublingual nifedipine in the presence of magnesium sulfate because of the risk of abrupt hypotension – European Society of Cardiology safety warning (European Heart Journal, 2020) 12.
• Do not use ACE inhibitors during the second and third trimesters, as they are absolutely contraindicated – European Society of Cardiology contraindication list (European Heart Journal, 2003) 16.

Evidence‑Based Guidelines for Preeclampsia Management

Delivery Timing

• For preeclampsia without severe features, expectant management with close maternal‑fetal monitoring is appropriate before 37 weeks gestation; delivery is recommended at ≥ 37 weeks. 17, 18
• For preeclampsia with severe features, delivery is recommended at ≥ 34 weeks gestation because of the high risk of rapid maternal clinical deterioration. 17, 18

Blood Pressure Management

• Acute severe hypertension (systolic ≥ 160 mmHg or diastolic ≥ 110 mmHg) must be treated within 15 minutes to prevent maternal stroke and other end‑organ damage. 17, 18
• For non‑severe hypertension (140–159/90–109 mmHg), treatment thresholds differ by guideline: the American College of Obstetricians and Gynecologists (ACOG) recommends initiating therapy at ≥ 160/110 mmHg, whereas the International Society for the Study of Hypertension in Pregnancy (ISSHP) recommends treatment at ≥ 140/90 mmHg. 18

Fluid Management

• Total intravenous fluid intake should be limited to 60–80 mL per hour to prevent iatrogenic pulmonary edema in women with preeclampsia. 17

Post‑partum Care

• Blood pressure monitoring should be performed at least every 4–6 hours while awake for a minimum of three days after delivery. 17
• Severe‑range hypertension (≥ 150/100 mmHg) is treated as a medical emergency up to six weeks postpartum because of the risk of postpartum preeclampsia. 17, 18